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Summary A proteolysis-inducing factor (PIF) isolated from a cachexia-inducing murne tumour (MAC16) produced a decrease in body weight
(1.6 g, P. 0.01 compared with control subjects) within 24 h after i.v. administration to non-tumour-bearing mice. Weight loss was associated
with significant decreases in the weight of the spleen and soleus and gastrocnemius muscles. with no effect on the weight of the heart or
kidney and with an increase in weight of the liver. Protein degradation in isolated soleus muscle was signfficantly increased in mice bearing the
MAC16 tumour. To define which proteolytic pathways contribute to this increase, soleus muscles from mice bearing the MAC16 tumour and
non-tumour-bearing animals administered PIF were incubated under conditions that modify different proteolytic systems. In mice bearing the
MAC16 tumour, there were increases in both cathepsin B and L, and the Ca2--dependent lysosomal and ATP-dependent pathways were found
to contribute to the increased proteolysis; whereas, in PIF-injected animals, there was activation only of the ATP-dependent pathway. Further
studies in mice bearing the MAC16 tumour have provided evidence for increased levels of ubiquitin-conjugated proteins and increased mRNA
levels for the 14 kDa ubiquitin carrier protein E2 and the C9 proteasome subunit in gastrocnemius muscle, suggesting activation of the
ATP-ubiquitin-dependent proteolytic pathway. A monoclonal antibody to PIF attenuated the enhanced protein degradation in soleus muscle
from mice bearing the MAC16 tumour, confirming that PIF is responsible for the loss of skeletal muscle in cachectic mice.
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W'eight loss is an important prognostic factor in determinin2 the
oxerall sur ix al of the cancer patient (Shamberger. 1984).
Although cancer cachexia is associated w-ith depletion of both
adipose tissue and skeletal muscle mass. it is x-isceral protein
and lean body mass depletion (as assessed by serum albumin
concentration and creatinine-heijht index) rather than adipose
depletion that haxe a w-orse prognostic impact (Nixon et al. 1980).
Peripheral muscle wasting may be due to increased muscle catabo-
lism or decreased protein synthesis. or a combination of the tx-o.
An increased rate of whole-body protein turnox er has been
reported in patients Awith colorectal cancer (Carmichael et al. 1980)
and non-oat-cell lung cancer (Melville et al. 1990). although the
incorporation ofleucine into skeletal muscle ofcancer patients has
also been found to be decreased (Lundholm et al. 1978).
To study this phenomenon. we have utilized the MAC16 murine
model of cachexia. which produces a decrease in muscle mass in
direct proportion to the w-eight of the tumour (Beck and Tisdale.
1987). This effect has been attributed to the production by the
tumour of a circulating proteolysis-inducing factor (PIF). which is
capable of initiating muscle catabolism in xitro (Smith and
Tisdale. 1993). This material has now been purified to homo-
ceneitv and showxn to be a sulphated glycoprotein of apparent
molecular weight of 24 kDa Todorox et al. 1996a). the actixitx- of
which can be neutralized by a monoclonal antibodx derix ed from
splenocxtes of mice bearin2 the MAC16 tumour (Todorox at al.
1996b.)
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Several proteolxtic pathwaxys are involxed in the intracellular
degradation of proteins in skeletal muscle: the l-sosomal
proteases. including the c!steine proteases. cathepsins B. H and L.
and the aspartate protease cathepsin D (Bird et al. 1980): a non-
I sosomal pathway involx ing the Ca'-actix ated cysteine proteases
calpain I and II (Waxman. 1981): an ATP-ubiquitin-dependent
proteolxtic pathwax (Hershko and Ciechanoxer. 1992): and a non-
lx sosomal ATP-dependent protease that cleaxes proteins that are
not conjugated to ubiquitin (Fagan and Waxman. 1989). The
ATP-ubiquitin-dependent proteolytic pathwax plaxys an important
role in muscle protein degradation induced by starvation (Wine
and Goldberg. 1993). sepsis (Tiao et al. 1994). metabolic acidosis
(Mitch et al. 1994). denerxation atrophv (Medina et al. 1995) and
cachexia induced by the Yoshida ascites hepatoma in rats (Llo era
et al. 1994: Baracos et al. 1995).
The present studx was initiated to determine which proteolytic
pathxwax is actix ated in skeletal muscle after administration of PIF
to non-tumour-bearing mice. and to compare the effect w-ith that
found in skeletal muscle of mice bearing the MAC16 tumour.
MATERIALS AND METHODS
Animals
Pure strain female NNIRI mice w-ere obtained from our ow-n
breeding colonv and were fed a rat and mouse breeding diet
)Pilsbur-. Birmin-ham. UK) and wxater ad libitum. Animals
(axerage bodv w-eight 20 g) were transplanted with fragments of
the MAC16 tumour into the flank by means of a trocar as prexi-
ouslv described (Beck and Tisdale. 1987). Weight loss started to
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occur 10-12 days after transplantation and the animals were killed
when the weight loss reached 15% ofthe starting weight.
Purification of a proteolysisinducing factor
Solid MAC16 tumours. excised from mice with established
cachexia. were homogenized. then precipitated by ammonium
sulphate (40% w/v) and the supematant was subjected to affinity
chromatography using a monoclonal antibody purified as
described previously (Todorov et al. 1996b). The immunogenic
fractions were further purified by hydrophobic chromatography
using a Brownlee Aquopore RP-300 C8 column and a gradient of
acetonitrile in water (Todorov et al. 1996a. 1996b).
Effect of proteolysis-inducing factor on body weight
The concentrate from the affinity chromatography was resus-
pended in phosphate-buffered saline (PBS) and concentrated with
an Amicon filtration cell (containing a filter with a molecular size
cut-off of 1OkDa). and portions (150il; 7 ji protein) were
injected into the tail vein offive female NMRI mice at 1.5 h inter-
vals (10.30. 12.00. 13.30 and 15.00 h). Animals were weighed
before each injection. with the final determination being made
24 h after the first injection. Control animals received PBS
(150gl) by tail vein injection. Both food and water intake were
monitored during the course ofthe experiment.
Detemination of the mechanism of muscle protein
degradation
Animals were killed by cervical dislocation and the soleus muscles
were quickly dissected out together with the intact tendons and
mounted on stainless-steel supports at resting length. They were
then transferred to 3 ml of oxygenated (95% oxygen:5% carbon
dioxide) Krebs-Henseleit bicarbonate buffer, pH 7.4. containing
5 mm glucose together with 0.5 n-m. cycloheximide, to prevent
reincorporation of amino acids released during proteolysis.
Muscles were preincubated for 45 min (except for energy-
depleting experiments, when the preincubation was for 60 min) at
37°C followed by an additional 2 h, during which the release of
tyrosine was determined by the fluorimetric method of Waalkes
and Udenfriend (1957). Tyrosine release gives a measurement of
total protein degradation. because tyrosine rapidly equilibrates
between intracellular pools and the medium and is neither synthe-
sized nordegraded.
To test the role of lysosomal proteolysis. muscles were incu-
bated in medium as described above or in medium containing
10 mms ammonium chloride. 250 jim chloroquine and 10 mtm
methylamine to block lysosomal acidification, together with
30 jim leupeptin. which inhibits lysosomal proteases (Lowell et al.
1986: Tawa et al. 1992: Baracos et al. 1995).
The role of calcium-dependent proteolysis was determined by
incubating muscles in medium from which calcium had been
omitted or in normal Krebs-Henseleit buffer that contained 2.5 m-s
calcium. In addition. muscles were incubated in the absence orpres-
ence of trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane
(E-64. 100 jM). which blocks calpains I and I (Barrett et al. 1982).
Muscles were also incubated in the presence of 10 mm methylamine
to inhibit lysosomal protein degradation so that differences in tyro-
sine release by muscles incubated with or without E-64 reflected
calcium-dependent proteolysis. For the determination of both
lysosomal and calcium-dependent proteolysis. the different
substances were present during both the preincubation period and
the 2 h incubation (Tawa et al. 1992: Baracos et al. 1995).
To study the role ofenergy-dependent proteolysis, muscles were
depleted of intracellular ATP by a 1 h preincubation in medium
containing 5 m-m deoxyglucose (2-DG) and 0.2 mim sodium azide
in the absence ofglucose. The muscles were then incubated for a
further 2 h and the tyrosine released compared with that from
muscles incubated in the presence of 5 mm glucose. Both sets of
muscles were incubated in Ca'+-free medium containing 10 mm
methylamine, 1 mU ml-' insulin and leucine. isoleucine and valine
present at concentrations five times that found in the plasma of
NMRI mice (Beck and Tisdale. 1989) to block lysosomal protein
degradation. Thus. changes in tyrosine release reflect non-lyso-
somal, Ca+-independent, energy-dependent proteolysis (Tawa et
al. 1992; Baracos et al. 1995).
Assay of cathepsins L and B
Animals were killed by cervical dislocation and the gastrocnemius
and soleus muscles were removed, trimmed completely of any
connective tissue and infringing muscle and washed twice with
10 ml of 250 mm sucrose. 2 nims EGTA. 2 m-m EDTA and 20 mm
Tris HCI. pH 7.4. The muscles were then individually homoge-
nized in 1 ml of 250 mm sucrose. 2 mM EGTA. 2 mms EDTA.
20 msm Tris HCI. pH 7.4. containing 0.2% Triton X-100. followed
by sonication. The supematants formed after centrifugation at
18 000g for 15 min were used to determine cathepsin activity.
For cathepsin L, the incubation mixture contained 0.1% Brij 35
in water (495 jl). (5 ji) supematant. 340 rms sodium acetate.
60 mm acetic acid. pH 5.5. 4 mM EDTA and 8 mM dithiothreitol
(250gl). and was preincubated for 5 min at 30°C before adding
the substrate N-CBZ-PHE-ARG-7-amido-4-methylcoumarin
(5 nmoles in 250 jl). After 10 min at 30°C. the reaction was termi-
nated by addition of 1 ml of 100 mM trichloroacetic acid. 100 mtm
sodium hydroxide. 30 mm sodium acetate and 70 mM acetic acid,
pH 4.3. The fluorescence of the free aminomethylcoumarin was
determined at an excitation wavelength of370 nm and an emission
wavelength of430 nm.
Cathepsin B was assayed in a similar manner using a buffer
composed of352 mM potassium dihydrogen phosphate and 48 mm
disodium hydrogen phosphate. pH 6.0. 4 mm EDTA. 8 mm
cysteine and Na-CBZ-Arg-Arg-7-amido-4-methylcoumarin
(2.5 nmol in 250gil) as substrate. The reaction was conducted for
lOmin at 400C and ternminated with 1 ml of l00 m sodium
chloroacetate. 30 mrs sodium acetate and 70 mm acetic acid.
pH 4.3. One unit of enzyme activity is defined as that amount
which catalyses the formation of 1 pmol ofproduct from substrate
during the 10 min incubation period.
RNA isolation and Nortrn blot analysis
Total RNA was extracted from gastrocnemius and soleus muscles.
and heart and liver using the acid guanidinium isothiocyanate/
phenollchloroform-isoamylalcohol method (Chomezynski and
Sacchi. 1987) and quantitated by absorbance at 260 nm.
The RNA was denatured by heating at 65°C for 10 min and
samples (10 jg) were subjected to electrophoresis on 1.2%
agarose gels containing 0.67% formaldehyde and transferred onto
a Genescreen membrane (NEN Research Products. MA. USA)
overnight by capillary action. The RNA was cross-linked to the
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Table 1 Effect of PIF on total body weight and the wet weights of tissues
and organs 24 h after administratiown
Control (g) P1F (g) P-valueb
Body weight change + 0.13 - 0.11 -1.60 0.42 <0.01
Spleen 0.131 - 0.023 0.048 0.018 <0.01
Kidney 0.196 0.009 0.191 0.012 NS
Heart 0.121 0.025 0.156 -0.014 NS
Liver 0.828- 0.028 0.916 0.029 <0.05
Soleus muscle 0.006 = 0.0002 0.005 + 0.0003 <.0.005
Gastrocnemius muscle 0.132 = 0 023 0.048 0 018 <0.01
aResults are expressed as means - s.e.m. for five mice per group. :Statistical
anatysis was performed using the unpaired Student's f-test.
membrane using a Spectrolink-er XL-1000 UV cross-linker
i120 000 mJ cm-') and the membrane allow-ed to drx. To check the
integntx of the RNA and to ensure proper transfer. bands w-ere
Xisualized under LV light after stainin, with ethidium bromide.
PrehO bridization was performed in 507e formamide. 10%-
dextran sulphate. 1 ml sodium chloride. 0.2% bomine serum
alburmin (BSA). 0.2'; polvxinylpyrolidone. 0.2Cc Ficoll. 0.1kc
sodium pxrophosphate. I1%q sodium dodecyl sulphate (SDS) and
50 mm Tris HCI. pH 7.5. together with 100 ge ml-' of denatured
salmon sperm DNA at 42 C oxerniaht. Radiolabelled probes
for E2 (WN'inse and Banville. 1994) and C9 (Kumatori et al.
1990) together w-ith glvceraldehx\de-3-phosphate dehydrogenase
(GAPDH) as internal standard w-ere prepared using the Amersham
Megaprime DNA labelling svstem according to the manufacturer's
instructions. Hvbridization \vas performed at 42-C. overnitht. in
the same buffer as for preh-bridization in the presence of dena-
tured labelled probes (2.2 x I0 d.p.m. per 30 pl). The membrane
w-as washed txwice with 30 mmt trisodium citrate and 300 mxt
sodium chloride (2 x SSC buffer) followxed bv incubation tx ice for
1 h xwith SSC - 1C/ SDS and a final xxash wxith 0.1 x SSC for 5 min
at room temperature. The filters xere scanned xith a Packard
Instant Imager svstem and finallx subjected to autoradiography.
Statistical analysis
Values are presented as means + s.e.m. Differences from control
xalues were determined bx Student's t-test.
RESULTS
The changes in total bodv wxeight and the wxeight of some indi-
xidual organs 24 h after administration ofthe PIF to female NMRI
mice are showxn in Table 1. Whereas control animals shoxxed a
small wei2ht increase 10.7%-). there wxas a siunificant (P< 0.01)
decrease in oxerall bodxweight (8.6%) in treated animals. The
effect on the tissues and oruans was x-ariable. Thus. there wxas a
sinificant decrease in the weight of the soleus and g!astrocnemius
muscles and spleen. no change in the xxeight of the heart and
kidnev. but an increase in weight of the lixer (Table 1.
To determine the mechanism for the selectixve depletion of
skeletal muscle in cachexia a comparison has been made on the
loss of soleus muscle induced bv PIF and the MAC16 tumour.
The effect of blocking l-sosomal function wxith methxlamine. an
inhibitor of l-sosomal acidification. on protein degradation
induced bv the MAC16 tumour was inxestigated (Table 2). There
wxas an increased catabolism of soleus muscle proteins in mice
Table 2 The effect of inhibition of lysosomal function with methylamine on
protein degradation in soleus muscle of control mice (C) and those bearing
the MAC16 tumour (T)
Protein degradation
Addition (Wnmol tyrosine g-1 2 h-1)
C T P-value
None 422- 34 695 + 3 0.001
Methylamine 433 -28 554 - 31 0 03
P-valuea NS 0.01
aStatistical analysis was performed using the unpaired Studenfs f-test. NS.
not significant.
Table 3 Activity of lysosomal cathepsins in muscle from control mice (C)
and those bearing the MAC16 tumour (T)
Muscle type Enzyme acbvity (U mg-' protein)a
C T P-valueb
Cathepsin L
Gastrocnemius 10 750 + 246 11 770 502 NS
Soleus 10 260 + 1140 59 750 3150 0.002
Cathepsin B
Gastrocnemius 51.5 + 17.3 401 + 39 0.02
aValues are expressed as means + s.e.m. for six mice per group. -Statistical
analysis was performed using the unpaired Student's f-test. NS. not
significant.
Table 4 The effect of inhibition of Ca2--dependent proteoltic system on
protein degradation in soleus muscle of control mice (C) and those bearing
the MAC16 tumour (T)
Protein degradation
Addition (umol tyrosine g-' 2 hp
C T P-valuea
Calcium chloride 395 -26 741 = 29 0.001
No Ca2- + inhibitors 362 -15 535 -5 0.003
P-valuea NS 0.01
aStatistical analysis was performed using the unpaired Student's f-test. NS.
not significant.
Table 5 The effect of inhibition of ATP production on protein degradation in
soleus muscle of control mice (C) and those bearing the MAC16 tumour (T)
Protein degradation
Addition (imol tyrosine g-1 2 h')
C T P-value
None 521 -21 674 62 0.01
Inhibitors 497 59 496 32 NS
P-valuea NS 0.01
aStatistcal anatysis was performed using the unpaired Student's f-test. NS.
not significant.
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Table 6 The effect of inhibiion (I) of tysosomal, Ca2--dependent and ATP-
dependent proteolytc pathlways on protein degradation in control (C) and
mice treated with PIF (T)a
Protein -
Type of proteoly (gmol tyrosin g1 2 hrl)b
C T P-value
Lysosomal
(-) 177 ± 16 228 ± 10 0.05
(+1) 153 ± 14 204 ±14 0.05
P-value NS NS
Ca2--depereht
(-) 234 ±8 268 ± 20 0.05
(+I) 192± 13 249± 16 0.05
P-value NS NS
ATP-dependent
(4) 250 ± 13 302 ± 20 0.05
(+I) 238 ± 10 214 ± 25 NS
P-value NS 0.05
aProtein degradation was measured in soleus muscle 24 h after i.v. injection
of PBS (C) or PIF (T). bVaJues are expressed as means ± s.e.m. for five mice
per group. Differences between groups with (+L) or without (-L) the inhibitor
were determined by Student's t-test
Table 7 Effect of a monolonal antibody (Ab) to PIF on protein degradation
in soleus muscle of mice bearng the MAC16 tumoure
Group (Wmol tyrosine g 2 h-')
MAC16 823 ± 82
MAC16 + Ab 482 ± 29
P-value 0.01
aMice osingweight bearing the MAC16 tumour wererandomized to receive
either no treatment or a ffmonoclna antbody to PIF administered i.p. at
0.4 mg b.d. for 48 h. Durng this time mice receiving no treatment ost
1.3 ± 0.4 g while those receiving antbody lost 0.9 ± 0.7g.
A
bearinc the MAC16 tumour. and methylamine caused a significant
decrease in overall proteolysis in soleus muscle oftumour-bearing
mice but not in non-tumour-bearing controls. Thus. there is a rise
in the lysosomal proteolytic process in muscles of mice bearing
the MAC16 tumour. This was confirmed by measurement of the
level ofthe lysosomal enzymes cathepsins L and B. There was an
elevation of cathepsin L in the soleus muscle from mice bearing
the MAC16 tumour (Table 3) and an increase in cathepsin B in
gastrocnemius muscle. This suggests that a significant proportion
of the increased proteolysis was due to an elevation ofthese lyso-
somal enzymes.
To determine whether the increase in protein degradation was
also due to activation of the non-lysosomal calcium-dependent
pathway. soleus muscles from tumour-bearing, and non-tumour-
bearing mice were incubated under conditions known to block
calpains I and II and in the absence ofcalcium. There was a signif-
icant reduction in the rate of protein degradation in the soleus
muscle of mice bearing the MAC16 tumour but not in the non-
tumour-bearing control group (Table 4). suggesting that the
calcium-dependent pathway also contributed to protein degrada-
tion in skeletal muscle ofmice bearing the MAC16 tumour.
To study the role of the ATP-dependent pathway in protein
degradation in soleus muscle induced by the MAC16 tumour.
muscles were depleted of ATP after blocking lysosomal and
calcium-dependent proteolytic pathways. Under these conditions.
protein degradation in non-tumour-bearing animals was not signif-
icantly reduced. whereas protein degradation in tumour-bearing
mice was significantly reduced (Table 5). There was no significant
difference in protein degradation between tumour-bearing and
control muscles in the presence of inhibitors. Under these condi-
tions. the ATP content of the muscles was reduced by an average
of 73%. Thus, an ATP-dependent non-lysosomal pathway appears
to play a major role in the excessive proteolysis ofskeletal muscle
in mice bearing the MAC16 tumour.
To investigate whetherthis was dependent on ubiquitin. gastroc-
nemius muscle from mice bearing the MAC16 tumour was
homogenized and the soluble protein was subjected to electro-
phoresis. immunoblotted and probed with an antibody that specif-
ically recognized ubiquitin-conjugated proteins. As reported by
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Figure 1 (A) Ubiquitn-protein conjugates in gastonmus muscle of non-tumour-bearing mice (lnes 1-3), mice treated for 24 h with PIF (lanes 4-6) and
mice bearing the MAC16tunujr (Lanes 7-9). (8) Scanning densitometry of theblot in (A) expressed in arbitrary units. Results are expressed as means ± s.e.m.
and differences from non-bxnour-bearing animral are expressed as ', P<0.05, as determined using the unpaired Sbtdenfs f-test
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Figure 2 (A) Northem blot of gastrocnemius musce from non-tumour-bearing mice (lanes 1-4). mice bearing the MAC13 tumour (lanes 5-8) and mice
bearing the MAC16 tumour (lanes 9-11) 14 days after tumour transplantation. The blots were probed for expression of the 14-kDa ubiquitin carrier protein E2.
(B) Scanning densitometry of the blot in (A) expressed in arbitrary units for non-tumour-bearing mice (open boxes), mice bearing the MAC13 tumour (hatched
boxes) and mice bearing the MAC16 tumour (solid boxes). Results are expressed as means + s.e.m. and differences from non-tumour-bearing animals are
expressed as ". P<0.01 and "'. P<0.001. as determined using the unpaired Student's t-test-
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Figure 3 (A) Northem blot of gastrocnemius musce from non-tumour-bearing mice (lanes 1-4). mice bearing the MAC13 tumour (lanes 5-8) and mice
bearing the MAC16 tumour (lanes 9-11) 14 days after tumour transplantation. The blots were probed for expression of the C9 proteasome subunit.
(B) Scanning densitometry of the blot in (A) expressed in arbitrary units for non-tumour-bearing mice (open boxes). mice bearing the MAC13 tumour
(hatched boxes) and mice bearing the MAC16 tumour (solid boxes)
other xworkers (IWing et al. 1995.) diffuse stainin5 bx the antibods
w-as detected in the high molecular mass region (100-200 kDa) of
the gel (Figure 1). Scanning densitometrv of the blot shozed a
42c elexation in the amount of the high molecular mass conju-
gates of ubiquitin in the soluble gastrocnemius muscle proteins
from mice bearing the M1AC16 tumour. as w-ell as a sianificant
elevation in PIF-treated mice (Figure 1). This suggests that the
ATP-ubiquitin-dependent proteolI tic pathw-ay was activated.
Because ubiquitin has roles other than in proteolI-sis (St John et al.
1986). the mRNA encoding other components ofthe pathway was
inxestigrated. Equal amounts of RNA from gastrocnemius muscles
of non-tumour-bearinm mice. mice bearing0 the non-cachexia-
inducing MAC13 tumour and the MAC16 tumour were compared
bx Northern hNbridization analvsis. The RNA blots w-ere probed
with the cDNA of the 14-kDa ubiquitin carrier protein E2. which
either ligates the ubiquitin directlx to the target protein or does so
in the presence of ubiquitin protein ligase. Two mRNA transcripts
of 1.2 and 1.8 kb w-ere detectable w-ith this probe. arising from
different sites of polvadenylation (Figure 2). Although there was
on1v a small change in the level of expression of the 1.8 kb
transcript (26%k increase). there >-as a large atwofold) increase in
the expression of the 1.2 kb transcript in gastrocnemius muscle of
mice bearing the MAC16 tumour and onlv a small increase in
muscle from mice bearing the MAC13 tumour. The RNA blots
w-ere also probed for the C9 subunit of the 20S proteasome. the
proteolvtic core of the 26S proteasome which degrades ubiquitin
conjugates (Hershko and Ciechanover. 1992) (Figure 3). This
show-ed a threefold increase in the 1.3 kb transcript in the gastroc-
nemius muscle of mice bearing the MIAC16 tumour. w-ith no
significant change in muscle from mice bearing the MAC13
tumour. Control experiments showed that the level of mRNA for
GAPDH. a housekeeping gene unrelated to protein breakdow-n.
Awas similar in all three groups of mice (results not shown).
confirminc that the differences in mRNA for steps in the
-ATP-ubiquitin-dependent proteolytic pathw-ay in skeletal muscle
of mice bearinr the MAC16 tumour were not due to non-specific
changes in the levels of all mRNA transcripts.
The effect of PIF on protein degradation in soleus muscle is
show-n in Table 6. In this case. onlv the ATP-dependent non-lyso-
somal pathway was actix ated. with no contribution from either the
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lysosomal or calcium-dependent pathways. This result suggests
that the ATP-dependent pathway is the primary event in the degra-
dation of skeletal muscle by PIF.
To determine whether PIF was responsible for activation of
protein degradation in skeletal muscle ofmice bearing the MAC16
tumour. mice that were losinc wei2ht were treated with a mono-
clonal antibody for PIF (Todorov et al. 1996b) and the extent of
protein degradation in soleus muscle was determined. The results
presented in Table 7 show an attenuation of the enhanced tyrosine
release in muscles from mice bearing the MAC16 tumour treated
with antibody. This confirms that PIF is responsible for loss of
skeletal muscle in cachectic mice bearing the MAC16 tumour.
DISCUSSION
Loss of muscle mass durinc the process of cachexia in mice
beann the MAC16 tumour is associated with the appearance of a
PIF in the circulation. which we have shown to be a sulphated
glycoprotein of molecular weight 24 kDa (Todoro- et al. 1997).
Evidence that this material is responsible for the protein degrading
activity in serum has been provided with the use of a monoclonal
antibody to the 24 kDa glycoprotein. which was capable of
neutralization ofbioloaical activity in v-itro (Todorov et al. 1996b)
Furthermore. the PIF appears to be responsible for wasting of
skeletal muscle in mice bearing the MAC16 tumour. because the
pol-unsaturated fatty acid. eicosapentaenoic acid (EPA). which we
have shown to significantly reduce protein degradation in viVo
(Beck et al. 1991). also attenuated protein degradation in vitro
initiated by PIF (Lorite et al. 1997). As the PIF induces protein
dearadation in isolated skeletal muscle. it suggests that the in viVo
effects could arise directly without the intervention of other medi-
ators. Indeed. administration of PIF to non-tumour-bearinn mice
elicits many changaes similar to those seen in cachexia. w-ithout a
depression in food and water intake. Cv-tokine-mediated effects are
characterized by a drop in food and water intake (Matthys and
Billiau. 1997). thus distinauishinc, the action of PIF from the
cvtokines. In addition to a marked decrease in overall body- weiuht
(8.6%' in 24 h). there were differential effects on the various
tissues and organs reminiscent of the effects of some tumours.
Thus. PIF induced a decrease in weight ofboth gastrocnemius and
soleus muscles. although ha-in2 no effect on the heart and kidney
and an increase in weiTht ofthe liver. This suggests that the action
of PIF is mediated predominantly on skeletal muscle.
Rats transplanted with the Yoshida ascites hepatoma show-
similar changes in the weight of the gastrocnemius muscle. liver
and heart (Baracos et al. 1995). and show activation ofproteol-tic
pathways in skeletal muscle similar to those observed in the
MAC16 tumour in the present study. Thus in both models. protein
degradation arose from an increase in both a lvsosomal and an
ATP-dependent proteolvtic pathway-. but in the Yoshida model
there was no contribution from the calcium-dependent proteolv-tic
system. Skeletal muscle contains at least two energy-dependent
proteolytic systems. one ofwhich is dependent on ubiquitin (Fagan
et al. 1987) and the other independent (Fagan and Waxman. 1989).
The former system has been suggested to be mainly responsible for
muscle atrophy in Yoshida sarcoma-bearing rats (Temparis et al.
1994) and those bearing the Yoshida ascites hepatoma (Baracos et
al. 1995). and appears to be of major importance in mice bearint
the MAC16 adenocarcinoma. An increase in the ATP-ubiquitin-
dependent proteolv-tic system in 2astrocnemius muscles of mice
bearing the MIAC16 tumour was supported by the finding of
increased levels ofubiquitin-conjugated proteins ofhigh molecular
mass. Such large conjugates have been found to be preferentially
degraded by the 26S proteasome complex in vitro (Hershk-o and
Ciechanover. 1992). The accumulation of ubiquitin conjugates
suggrests an increased flux ofproteins through the pathway and that
the hydrolysis by the 26S proteasome becomes rate limiting
(Baracos et al. 1995). Northern blot anal-sis showed an up-regula-
tion of the mRNA for the 14-kDa E2 involved in substrate ubiqui-
tvlation and the rate-limiting, step in the ubiquitin conjugation
pathway (Wing, and Banville. 1994). The 1.2-kb transcript in
skeletal muscle has been reported to increase threefold after 2 days
of fasting, without a sinnificant change in the 1.8-kb transcript
(Wing, and Banville. 1994). In animals bearing the M,AC16 tumour.
there was also a twofold increase in expression of the 1.2-kb tran-
script in gyastrocnemius muscle and a small (26%) increase in the
1.8-kb transcript. although there was no reduction in food intake
(Beck and Tisdale. 1987). An enhanced production of proteasomes
also seems likelv from the threefold rise in the mRNA for the
proteasome subunit C9.
The ATP-dependent. but not the lysosomal. pathway was also
activated in soleus muscle of non-tumour-bearin, mice 24 h after
administration of PIF. although experinents have not been
performed to date to investigate whether this is the ubiquitin-
dependent pathway. However. it is likely that PIF contributes
directly to the activation ofthis pathwav in skeletal muscle of mice
bearinc the MAC16 tumour, because antibodies to PIF attenuate
the degradation of skeletal muscle proteins. There are other poten-
tial mediators such as tumour necrosis factor (x (TNT-a) and inter-
leukin 6 (IL-6). which could act in vivo. TNF-a has been shown to
produce an increase in ubiquitin aene expression in -itro after incu-
bation for 180 mmn. although there was no change in the expression
of the C8 proteasome subunit. which may require a longer time
interval for induction (Llovera et al. 1997). IL-6 has also been
found to increase the activity of the 26S proteasome in murine
C2C, myotubes in vitro (Ebisui et al. 1995). However. our previous
studies (Mulligan et al. 1992) have failed to find anv evidence for
an involvement ofeither TNT-a or IL-6 in the process of cachexia
induced by the MAC16 tumour. suggestinc that PIF may be
directly involved. Further studies are required to dissect out the
molecular pathways involved in protein degradation.
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